111 related articles for article (PubMed ID: 8956977)
1. Pentoxifylline delays the onset of experimental allergic encephalomyelitis in mice by modulating cytokine production in peripheral blood mononuclear cells.
Okuda Y; Sakoda S; Fujimura H; Yanagihara T
Immunopharmacology; 1996 Nov; 35(2):141-8. PubMed ID: 8956977
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells.
Neuner P; Klosner G; Schauer E; Pourmojib M; Macheiner W; Grünwald C; Knobler R; Schwarz A; Luger TA; Schwarz T
Immunology; 1994 Oct; 83(2):262-7. PubMed ID: 7835945
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of TNF alpha, IL-1 beta, IL-6, IL-8, TNF beta, and IL-10 by pentoxifylline.
D'Hellencourt CL; Diaw L; Cornillet P; Guenounou M
Int J Immunopharmacol; 1996 Dec; 18(12):739-48. PubMed ID: 9172017
[TBL] [Abstract][Full Text] [Related]
4. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.
Renno T; Krakowski M; Piccirillo C; Lin JY; Owens T
J Immunol; 1995 Jan; 154(2):944-53. PubMed ID: 7814894
[TBL] [Abstract][Full Text] [Related]
5. The pattern of cytokine gene expression in lymphoid organs and peripheral blood mononuclear cells of mice with experimental allergic encephalomyelitis.
Okuda Y; Sakoda S; Yanagihara T
J Neuroimmunol; 1998 Jul; 87(1-2):147-55. PubMed ID: 9670856
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline inhibits experimental allergic encephalomyelitis.
Nataf S; Louboutin JP; Chabannes D; Fève JR; Muller JY
Acta Neurol Scand; 1993 Aug; 88(2):97-9. PubMed ID: 8213066
[TBL] [Abstract][Full Text] [Related]
7. The differential effect of pentoxifylline on cytokine production by alveolar macrophages and its clinical implications.
Poulakis N; Androutsos G; Kazi D; Bastas A; Provata A; Bitsakou C; Kontozoglou T; Polyzogopoulou C; Tassiopoulou A
Respir Med; 1999 Jan; 93(1):52-7. PubMed ID: 10464849
[TBL] [Abstract][Full Text] [Related]
8. Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis.
Weber F; Polak T; Günther A; Kubuschok B; Janovskaja J; Bitsch A; Poser S; Rieckmann P
Ann Neurol; 1998 Jul; 44(1):27-34. PubMed ID: 9667590
[TBL] [Abstract][Full Text] [Related]
9. Differential modulation of IL-8 and TNF-alpha expression in human keratinocytes by buflomedil chlorhydrate and pentoxifylline.
Redondo P; García-Foncillas J; España A; Cuevillas F; Quintanilla E
Exp Dermatol; 1997 Aug; 6(4):186-94. PubMed ID: 9293391
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor necrosis factor production and ICAM-1 expression by pentoxifylline: beneficial effects in sepsis syndrome.
Mándi Y; Farkas G; Ocsovszky I; Nagy Z
Res Exp Med (Berl); 1995; 195(5):297-307. PubMed ID: 8579638
[TBL] [Abstract][Full Text] [Related]
11. Immune response modulation by pentoxifylline in vitro.
Tilg H; Eibl B; Pichl M; Gächter A; Herold M; Brankova J; Huber C; Niederwieser D
Transplantation; 1993 Jul; 56(1):196-201. PubMed ID: 8333042
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells.
Schandené L; Vandenbussche P; Crusiaux A; Alègre ML; Abramowicz D; Dupont E; Content J; Goldman M
Immunology; 1992 May; 76(1):30-4. PubMed ID: 1385797
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline inhibits endotoxin-induced NF-kappa B activation and associated production of proinflammatory cytokines.
Ji Q; Zhang L; Jia H; Xu J
Ann Clin Lab Sci; 2004; 34(4):427-36. PubMed ID: 15648785
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease.
Reimund JM; Dumont S; Muller CD; Kenney JS; Kedinger M; Baumann R; Poindron P; Duclos B
Gut; 1997 Apr; 40(4):475-80. PubMed ID: 9176074
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-beta and interleukin-10.
Crisi GM; Santambrogio L; Hochwald GM; Smith SR; Carlino JA; Thorbecke GJ
Eur J Immunol; 1995 Nov; 25(11):3035-40. PubMed ID: 7489740
[TBL] [Abstract][Full Text] [Related]
17. Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains.
Chung IY; Norris JG; Benveniste EN
J Exp Med; 1991 Apr; 173(4):801-11. PubMed ID: 1901078
[TBL] [Abstract][Full Text] [Related]
18. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis.
Okuda Y; Sakoda S; Fujimura H; Saeki Y; Kishimoto T; Yanagihara T
J Neuroimmunol; 1999 Nov; 101(2):188-96. PubMed ID: 10580801
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of Interleukin-9 Decreasing Mast Cells Infiltration in Experimental Autoimmune Encephalomyelitis.
Yin JJ; Hu XQ; Mao ZF; Bao J; Qiu W; Lu ZQ; Wu HT; Zhong XN
Chin Med J (Engl); 2017 Apr; 130(8):964-971. PubMed ID: 28397727
[TBL] [Abstract][Full Text] [Related]
20. Effect of thalidomide and pentoxifylline on experimental autoimmune encephalomyelitis (EAE).
Corrêa JO; Aarestrup BJ; Aarestrup FM
Exp Neurol; 2010 Nov; 226(1):15-23. PubMed ID: 20406639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
